EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bioorthogonal Bond Cleavage Chemistry for On-demand Prodrug Activation: Opportunities and Challenges

Qingqiang Min, Xingyue Ji iD

Journal of Medicinal Chemistry · 28.12.2023 · 66 (24) · 16546-16567

DOI: 10.1021/acs.jmedchem.3c01459 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 12.12.2023. Verfasst von Qingqiang Min und 1 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, College of Pharmaceutical Science, Soochow Univer…. Hauptthemen laut MEDLINE: Prodrugs. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 139 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Time- and space-resolved drug delivery is highly demanded for cancer treatment, which, however, can barely be achieved with a traditional prodrug strategy. In recent years, the prodrug strategy based on a bioorthogonal bond cleavage chemistry has emerged with the advantages of high temporospatial resolution over drug activation and homogeneous activation irrespective of individual heterogeneity. In the past five years, tremendous progress has been witnessed in this field with one such bioorthogonal prodrug entering Phase II clinical trials. This Perspective aims to highlight these new advances (2019-2023) and critically discuss their pros and cons. In addition, the remaining challenges and potential strategic directions for future progress will also be included.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsDrug Delivery Systems

Substanzen

Prodrugs

Autor:innen und Institutionen

  • Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, College of Pharmaceutical Science, Soochow University, Suzhou 215123, China.

ORCID-Profile: Xingyue Ji

Förderung

  • National Natural Science Foundation of China
  • Priority Academic Program Development of Jiangsu Higher Education Institutions

Zitieren

APA

Min, Q., & Ji, X. (2023). Bioorthogonal Bond Cleavage Chemistry for On-demand Prodrug Activation: Opportunities and Challenges. Journal of Medicinal Chemistry, 66(24), 16546-16567. https://doi.org/10.1021/acs.jmedchem.3c01459

Vancouver

Min Q, Ji X. Bioorthogonal Bond Cleavage Chemistry for On-demand Prodrug Activation: Opportunities and Challenges. Journal of Medicinal Chemistry. 2023;66(24):16546-16567. doi:10.1021/acs.jmedchem.3c01459

BibTeX
@article{Min2023,
  author = {Min, Qingqiang and Ji, Xingyue},
  title = {Bioorthogonal Bond Cleavage Chemistry for On-demand Prodrug Activation: Opportunities and Challenges},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {24},
  pages = {16546--16567},
  doi = {10.1021/acs.jmedchem.3c01459}
}
Kostenlos starten →